- Correction
- Open access
- Published:
Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells
Stem Cell Research & Therapy volume 9, Article number: 261 (2018)
Correction
The original article [1] contains numerous value errors in the graphs in Fig. 2b regarding the markers describing the values for total tubule length and mean tubule length without aprotinin at 2.5 mg/ml concentration of fibrinogen. The corrected version of this figure can be viewed ahead.
![figure a](http://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-018-1001-3/MediaObjects/13287_2018_1001_Figa_HTML.png)
Reference
Mühleder S, et al. The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells. Stem Cell Res Ther. 2018;9:35. https://doi.org/10.1186/s13287-017-0764-2
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Mühleder, S., Pill, K., Schaupper, M. et al. Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells. Stem Cell Res Ther 9, 261 (2018). https://doi.org/10.1186/s13287-018-1001-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13287-018-1001-3